Skip to main content
  • 1228 Accesses

Abstract

Atrial fibrillation (AF) is defined as an unpredictable activation of the atria, causing an irregular ventricular response. It is characterized electrocardiographically by irregular fibrillatory waves, usually associated with an irregular ventricular response, which manifests clinically as an irregular pulse. AF is the most common sustained rhythm disorder or arrhythmia encountered in clinical practice with a prevalence of 1% in the general population, which increases with age to about 6% in people over the age of 65,1-3 and it is responsible for over one-third of all cardioembolic episodes.4

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-952

    CAS  PubMed  Google Scholar 

  2. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998;32(3):695-703

    Google Scholar 

  3. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155(5):469-473

    Google Scholar 

  4. Wolf PA, Singer DE. Preventing stroke in atrial fibrillation. Am Fam Physician. 1997;56(9):2242-2250

    CAS  PubMed  Google Scholar 

  5. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation. 2001;104(17):2118-2150

    CAS  PubMed  Google Scholar 

  6. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-e354

    Article  Google Scholar 

  7. Gersh BJ, Solomon A. Lone atrial fibrillation: epidemiology and natural history. Am Heart J. 1999;137(4 pt 1):592-595

    Article  CAS  PubMed  Google Scholar 

  8. Korantzopoulos P, Liu T, Milionis HJ, Li G, Goudevenos JA. “Lone” atrial fibrillation: hunting for the underlying causes and links. Int J Cardiol. 2009;131(2):180-185

    Article  PubMed  Google Scholar 

  9. Brugada R. Molecular biology of atrial fibrillation. Minerva Cardioangiol. 2004;52(2):65-72

    CAS  PubMed  Google Scholar 

  10. Barth AS, Merk S, Arnoldi E, et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res. 2005;96(9):1022-1029

    Article  CAS  PubMed  Google Scholar 

  11. Barth AS, Hare JM. The potential for the transcriptome to serve as a clinical biomarker for cardiovascular diseases. Circ Res. 2006;98(12):1459-1461

    Article  CAS  PubMed  Google Scholar 

  12. Wolff L. Familial auricular fibrillation. New Engl J Med. 1943;229:396

    Article  Google Scholar 

  13. Fox CS, Parise H, D’Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 2004;291(23):2851-2855

    Article  CAS  PubMed  Google Scholar 

  14. Arnar DO, Thorvaldsson S, Manolio TA, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J. 2006;27(6):708-712

    Article  PubMed  Google Scholar 

  15. Darbar D, Herron KJ, Ballew JD, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol. 2003;41(12):2185-2192

    Article  PubMed  Google Scholar 

  16. Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997;336(13):905-911

    Article  CAS  PubMed  Google Scholar 

  17. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation. 2003;107(23):2880-2883

    Article  PubMed  Google Scholar 

  18. Volders PG, Zhu Q, Timmermans C, et al. Mapping a novel locus for familial atrial fibrillation on chromosome 10p11-q21. Heart Rhythm. 2007;4(4):469-475

    Article  PubMed  Google Scholar 

  19. Darbar D, Hardy A, Haines JL, Roden DM. Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol. 2008; 51(11):1083-1089

    Article  PubMed  Google Scholar 

  20. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003;299 (5604):251-254

    Article  CAS  PubMed  Google Scholar 

  21. Hong K, Piper DR, Diaz-Valdecantos A, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res. 2005;68(3):433-440

    Article  CAS  PubMed  Google Scholar 

  22. Otway R, Vandenberg JI, Guo G, et al. Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol. 2007;49(5):578-586

    Article  CAS  PubMed  Google Scholar 

  23. Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet. 2004;75(5):899-905

    Article  CAS  PubMed  Google Scholar 

  24. Zhang DF, Liang B, Lin J, Liu B, Zhou QS, Yang YQ. [KCNE3 R53H substitution in familial atrial fibrillation.]. Chin Med J (Engl). 2005;118(20):1735-1738

    Google Scholar 

  25. Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun. 2005;332 (4):1012-1019

    Google Scholar 

  26. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet. 2006;15(14):2185-2191

    Google Scholar 

  27. Viswanathan PC, Balser JR. Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc Med. 2004;14(1):28-35

    Article  CAS  PubMed  Google Scholar 

  28. Darbar D, Kannankeril PJ, Donahue BS, et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation. 2008;117(15):1927-1935

    Article  CAS  PubMed  Google Scholar 

  29. Benito B, Brugada R, Perich RM, et al. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Heart Rhythm. 2008;5(10):1434-1440

    Article  PubMed  Google Scholar 

  30. Hodgson-Zingman DM, Karst ML, Zingman LV, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med. 2008;359(2):158-165

    Article  CAS  PubMed  Google Scholar 

  31. Zhang X, Chen S, Yoo S, et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell. 2008;135(6):1017-1027

    Article  CAS  PubMed  Google Scholar 

  32. Gollob MH, Jones DL, Krahn AD, et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med. 2006;354(25):2677-2688

    Article  CAS  PubMed  Google Scholar 

  33. Yamashita T, Hayami N, Ajiki K, et al. Is ACE gene polymorphism associated with lone atrial fibrillation? Jpn Heart J. 1997;38(5):637-641

    CAS  PubMed  Google Scholar 

  34. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90(5):2199-2202

    CAS  PubMed  Google Scholar 

  35. Tsai CT, Lai LP, Lin JL, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation. 2004;109(13):1640-1646

    Article  CAS  PubMed  Google Scholar 

  36. Ehrlich JR, Zicha S, Coutu P, Hebert TE, Nattel S. Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization. Cardiovasc Res. 2005;67(3):520-528

    Article  CAS  PubMed  Google Scholar 

  37. Lai LP, Lin JL, Huang SK. Molecular genetic studies in atrial fibrillation. Cardiology. 2003;100(3):109-113

    Article  CAS  PubMed  Google Scholar 

  38. Chen LY, Herron KJ, Tai BC, Olson TM. Lone atrial fibrillation: influence of familial disease on gender predilection. J Cardiovasc Electrophysiol. 2008;19(8):802-806

    Article  PubMed  Google Scholar 

  39. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003;108(suppl 1): II195-II199

    Google Scholar 

  40. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet. 1997; 17(3):338-340

    Article  CAS  PubMed  Google Scholar 

  41. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;448(7151):7353-7357

    Article  Google Scholar 

  42. Kaab S, Darbar D, van Noord C, et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J. 2009;30 (7):813-819

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

Campuzano, O., Brugada, R. (2010). Atrial Fibrillation. In: Brugada, R. (eds) Clinical Approach to Sudden Cardiac Death Syndromes. Springer, London. https://doi.org/10.1007/978-1-84882-927-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-927-5_14

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-926-8

  • Online ISBN: 978-1-84882-927-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics